JPWO2021222347A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021222347A5 JPWO2021222347A5 JP2022565804A JP2022565804A JPWO2021222347A5 JP WO2021222347 A5 JPWO2021222347 A5 JP WO2021222347A5 JP 2022565804 A JP2022565804 A JP 2022565804A JP 2022565804 A JP2022565804 A JP 2022565804A JP WO2021222347 A5 JPWO2021222347 A5 JP WO2021222347A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- region
- sequence shown
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063017061P | 2020-04-29 | 2020-04-29 | |
| US63/017,061 | 2020-04-29 | ||
| PCT/US2021/029545 WO2021222347A1 (en) | 2020-04-29 | 2021-04-28 | Pharmaceutical formulation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023524445A JP2023524445A (ja) | 2023-06-12 |
| JPWO2021222347A5 true JPWO2021222347A5 (https=) | 2024-03-28 |
| JP2023524445A5 JP2023524445A5 (https=) | 2024-03-28 |
Family
ID=76099008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022565804A Pending JP2023524445A (ja) | 2020-04-29 | 2021-04-28 | 医薬製剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230167176A1 (https=) |
| EP (1) | EP4142789A1 (https=) |
| JP (1) | JP2023524445A (https=) |
| KR (1) | KR20230004798A (https=) |
| CN (1) | CN115461080A (https=) |
| AU (1) | AU2021265108A1 (https=) |
| CA (1) | CA3173934A1 (https=) |
| IL (1) | IL297081A (https=) |
| WO (1) | WO2021222347A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202415407A (zh) * | 2022-06-30 | 2024-04-16 | 中國大陸商蘇州創勝醫藥集團有限公司 | 穩定之包含抗cldn18.2抗體的藥物製劑 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4475196A (en) | 1981-03-06 | 1984-10-02 | Zor Clair G | Instrument for locating faults in aircraft passenger reading light and attendant call control system |
| US4447233A (en) | 1981-04-10 | 1984-05-08 | Parker-Hannifin Corporation | Medication infusion pump |
| US4439196A (en) | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
| US4447224A (en) | 1982-09-20 | 1984-05-08 | Infusaid Corporation | Variable flow implantable infusion apparatus |
| US4487603A (en) | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
| US4486194A (en) | 1983-06-08 | 1984-12-04 | James Ferrara | Therapeutic device for administering medicaments through the skin |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| US4751180A (en) | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| US4935233A (en) | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
| ATE243754T1 (de) | 1987-05-21 | 2003-07-15 | Micromet Ag | Multifunktionelle proteine mit vorbestimmter zielsetzung |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| EP1299419A2 (en) | 2000-05-24 | 2003-04-09 | Imclone Systems, Inc. | Bispecific immunoglobulin-like antigen binding proteins and method of production |
| JP2008512352A (ja) | 2004-07-17 | 2008-04-24 | イムクローン システムズ インコーポレイティド | 新規な四価の二重特異性抗体 |
| CA2697922A1 (en) | 2007-08-28 | 2009-03-12 | Biogen Idec Ma Inc. | Compositions that bind multiple epitopes of igf-1r |
| KR20180008921A (ko) * | 2012-11-01 | 2018-01-24 | 애브비 인코포레이티드 | 항-ｖｅｇｆ／ｄｌｌ4 이원 가변 도메인 면역글로불린 및 이의 용도 |
| EP3498263B1 (en) * | 2016-08-10 | 2023-11-29 | Celltrion Inc. | Stable liquid pharmaceutical preparation for anti-influenza virus antibody |
| TN2019000225A1 (en) | 2017-02-02 | 2021-01-07 | Amgen Res Munich Gmbh | Low ph pharmaceutical composition comprising t cell engaging antibody constructs |
| MX2019013142A (es) * | 2017-05-05 | 2019-12-16 | Amgen Inc | Composicion farmaceutica que comprende construcciones de anticuerpos biespecificas para mejorar el almacenamiento y la administracion. |
| CN110869050B (zh) * | 2017-07-28 | 2024-07-02 | 豪夫迈·罗氏有限公司 | 双特异性抗体配制剂 |
-
2021
- 2021-04-28 JP JP2022565804A patent/JP2023524445A/ja active Pending
- 2021-04-28 KR KR1020227041361A patent/KR20230004798A/ko active Pending
- 2021-04-28 AU AU2021265108A patent/AU2021265108A1/en active Pending
- 2021-04-28 EP EP21727965.2A patent/EP4142789A1/en active Pending
- 2021-04-28 WO PCT/US2021/029545 patent/WO2021222347A1/en not_active Ceased
- 2021-04-28 US US17/921,794 patent/US20230167176A1/en active Pending
- 2021-04-28 CA CA3173934A patent/CA3173934A1/en active Pending
- 2021-04-28 CN CN202180030938.6A patent/CN115461080A/zh active Pending
-
2022
- 2022-10-04 IL IL297081A patent/IL297081A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6616931B1 (en) | Rotavirus vaccine formulations | |
| US5932223A (en) | Rotavirus vaccine formulations | |
| US6403098B1 (en) | Rotavirus vaccine formulations | |
| US20250242010A1 (en) | Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens | |
| CN113755523B (zh) | 重组前融合状态新冠刺突蛋白的制备方法 | |
| AU739916B2 (en) | Rotavirus vaccine formulations | |
| KR100695599B1 (ko) | 백신 | |
| KR20090021298A (ko) | 항-ｅｇｆｒ 항체의 동결건조 제제 | |
| JPH03504605A (ja) | 抗体産生物の凍結乾燥した配合物 | |
| JP2013100329A (ja) | 薬学的製剤 | |
| FR2995214A1 (fr) | Solution a viscosite reduite de proteine a concentration elevee | |
| JPWO2021222347A5 (https=) | ||
| JPWO2021222355A5 (https=) | ||
| WO2020223906A1 (en) | Stable albuvirtide compositions | |
| JPWO2022046651A5 (https=) | ||
| JPWO2021081326A5 (https=) | ||
| JPWO2023079086A5 (https=) | ||
| US20260014093A1 (en) | Atomic layer deposition (ald) processes applied to phage and phage-like particle platform yield thermostable therapeutic agents | |
| JPWO2022256359A5 (https=) | ||
| AU2008202660B2 (en) | Rotavirus vaccine formulations | |
| JPWO2022271544A5 (https=) | ||
| US20260014251A1 (en) | Compositions, methods, and uses for polynucleotide formulations for drying and prolonged storage | |
| AU2005201501A1 (en) | Rotavirus Vaccine Formulations | |
| RU2019124017A (ru) | Композиции neisseria meningitidis и способы | |
| JPWO2021087050A5 (https=) |